Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as CAGRILINTIDE PEPTIDE 5MG 10MG VIAL UMBRELLA Labs Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed